01681.HK
Consun Pharmaceutical Group Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 15.25
+0.73%Margins
Gross margin
80.1%
EBITDA margin
37.4%
EBIT margin
36.3%
Net margin
32.3%
FCF margin
42.6%
24.5%
Return on equity
17.1%
Return on assets
26.2%
Return on invested capital
0.55x
Asset turnover
HKD 1.9B
Cash from operations
HKD 5.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026